A single center study investigating ciclosporine A microemulsion in combination with basiliximab and prednisolone and switch to low-dose ciclosporine A and everolimus without steroids in the prevention of transplant nephropathy in pediatric renal allografts recipients.

Trial Profile

A single center study investigating ciclosporine A microemulsion in combination with basiliximab and prednisolone and switch to low-dose ciclosporine A and everolimus without steroids in the prevention of transplant nephropathy in pediatric renal allografts recipients.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2011

At a glance

  • Drugs Ciclosporin; Everolimus
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top